SCHEMBL4023946

SCHEMBL4023946

CCCCCc1c(-c2ccc3c(Br)c([O])ccc3c2)n(C)c2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 1/20 0.37
TSHR P16473 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
HSD11B1 P28845 2/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
SLC2A1 P11166 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
OXER1 Q8TDS5 1/20 0.34
TLR7 Q9NYK1 1/20 0.34
MCL1 Q07820 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4953627 0.88 PTPN1 (0.46) ALDH1A1HPGDHSD17B10MEN1TSHR
SCHEMBL4022869 0.82 PTPN1 (0.52) ALDH1A1HPGDHSD17B10
SCHEMBL5345667 0.81 ALDH1A1 (0.41) ALDH1A1HPGDHSD17B10MEN1TSHR
SCHEMBL4024325 0.81 PSEN1 (0.42) ALDH1A1HPGDHSD17B10RAB9ASMN1; SMN2
SCHEMBL4192744 0.79 ALDH1A1 (0.34) ALDH1A1HPGDHSD17B10MEN1TSHR
SCHEMBL4192748 0.78 ALDH1A1 (0.35) ALDH1A1HPGDHSD17B10MEN1TSHR
SCHEMBL4021086 0.76 PTPN1 (0.37) ALDH1A1HPGDHSD17B10MEN1TSHR
SCHEMBL4023360 0.76 ALDH1A1 (0.32) ALDH1A1HPGDHSD17B10MEN1TSHR
SCHEMBL4024279 0.73 PSEN1 (0.53) ALDH1A1HPGDHSD17B10MEN1TSHR
SCHEMBL4027205 0.70 PTPN1 (0.41) ALDH1A1HPGDRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1397356-B1 SUBSTITUTED NAPHTHYL INDOLE DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 (PAI-1) WYETH CORP (US) 2009-05-13 EP claimed
US-20080182883-A1 SUBSTITUTED NAPHTHYL INDOLE DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 (PAI-1) WYETH (US) 2008-07-31 US claimed
WO-2007092207-A1 COMPOSITIONS FOR THE DELIVERY OF SUBSTITUTED NAPHTHYL INDOLE DERIVATIVES AND METHODS OF THEIR USE WYETH (US) 2007-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080182883-A1 SUBSTITUTED NAPHTHYL INDOLE DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 (PAI-1) TFPI, SERPINE1, F12 ALDH1A1 897/4885HPGD 1899/4885HSD17B10 2494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.